Industry Growth Insights published a new data on “Antiasthmatic Drug Market”. The research report is titled “Antiasthmatic Drug Market research by Types (Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027, Bronchodilators, Anti-allergic Antiasthmatic, Anti-inflammatory Antiasthmatic), By Applications (Need for Acute Attack of Asthma, Treatment of Chronic Asthma), By Players/Companies Novartis AG, GlaxoSmithKline, ABC Farmaceutici Spa, AstraZeneca, Teva Pharmaceutical Industries Ltd, Mundipharma Pharmaceuticals Ltd., MSD, Daiichi Sankyo Company Limited, Chiesi GmbH, Kyorin Pharmaceutical Co.,Ltd., Kissei Pharmaceutical Co.Ltd., Ruiyang Pharmaceutical Co., Ltd, Chiesi Pharmaceutical (Shangai) Co., Ltd, Fuhe Group, Lunan Pharmaceutical Group Co., Ltd, Chengdu Huayu Pharmaceutical Co., Ltd, Kaifeng Kangnuo Pharmaceutical Co., Ltd, Akorn Pharmaceutical Co.Ltd., Boehringer Ingelheim Pharma GmbH&Co.KG, Covis Pharmaceutical Inc, Roche”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Antiasthmatic Drug Market Research Report
By Type
Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027, Bronchodilators, Anti-allergic Antiasthmatic, Anti-inflammatory Antiasthmatic
By Application
Need for Acute Attack of Asthma, Treatment of Chronic Asthma
By Companies
Novartis AG, GlaxoSmithKline, ABC Farmaceutici Spa, AstraZeneca, Teva Pharmaceutical Industries Ltd, Mundipharma Pharmaceuticals Ltd., MSD, Daiichi Sankyo Company Limited, Chiesi GmbH, Kyorin Pharmaceutical Co.,Ltd., Kissei Pharmaceutical Co.Ltd., Ruiyang Pharmaceutical Co., Ltd, Chiesi Pharmaceutical (Shangai) Co., Ltd, Fuhe Group, Lunan Pharmaceutical Group Co., Ltd, Chengdu Huayu Pharmaceutical Co., Ltd, Kaifeng Kangnuo Pharmaceutical Co., Ltd, Akorn Pharmaceutical Co.Ltd., Boehringer Ingelheim Pharma GmbH&Co.KG, Covis Pharmaceutical Inc, Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Antiasthmatic Drug Market Report Segments:
The global Antiasthmatic Drug market is segmented on the basis of:
Types
Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027, Bronchodilators, Anti-allergic Antiasthmatic, Anti-inflammatory Antiasthmatic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Need for Acute Attack of Asthma, Treatment of Chronic Asthma
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis AG
- GlaxoSmithKline
- ABC Farmaceutici Spa
- AstraZeneca
- Teva Pharmaceutical Industries Ltd
- Mundipharma Pharmaceuticals Ltd.
- MSD
- Daiichi Sankyo Company Limited
- Chiesi GmbH
- Kyorin Pharmaceutical Co.,Ltd.
- Kissei Pharmaceutical Co.Ltd.
- Ruiyang Pharmaceutical Co., Ltd
- Chiesi Pharmaceutical (Shangai) Co., Ltd
- Fuhe Group
- Lunan Pharmaceutical Group Co., Ltd
- Chengdu Huayu Pharmaceutical Co., Ltd
- Kaifeng Kangnuo Pharmaceutical Co., Ltd
- Akorn Pharmaceutical Co.Ltd.
- Boehringer Ingelheim Pharma GmbH&Co.KG
- Covis Pharmaceutical Inc
- Roche
Highlights of The Antiasthmatic Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027
- Bronchodilators
- Anti-allergic Antiasthmatic
- Anti-inflammatory Antiasthmatic
- By Application:
- Need for Acute Attack of Asthma
- Treatment of Chronic Asthma
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antiasthmatic Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An asthma drug is a medication used to treat asthma.
Some of the key players operating in the antiasthmatic drug market are Novartis AG, GlaxoSmithKline, ABC Farmaceutici Spa, AstraZeneca, Teva Pharmaceutical Industries Ltd, Mundipharma Pharmaceuticals Ltd., MSD, Daiichi Sankyo Company Limited, Chiesi GmbH, Kyorin Pharmaceutical Co.,Ltd., Kissei Pharmaceutical Co.Ltd., Ruiyang Pharmaceutical Co., Ltd, Chiesi Pharmaceutical (Shangai) Co., Ltd, Fuhe Group, Lunan Pharmaceutical Group Co., Ltd, Chengdu Huayu Pharmaceutical Co., Ltd, Kaifeng Kangnuo Pharmaceutical Co., Ltd, Akorn Pharmaceutical Co.Ltd., Boehringer Ingelheim Pharma GmbH&Co.KG, Covis Pharmaceutical Inc, Roche.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antiasthmatic Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antiasthmatic Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antiasthmatic Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antiasthmatic Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antiasthmatic Drug Market Size & Forecast, 2020-2028
4.5.1 Antiasthmatic Drug Market Size and Y-o-Y Growth
4.5.2 Antiasthmatic Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027
5.2.2 Bronchodilators
5.2.3 Anti-allergic Antiasthmatic
5.2.4 Anti-inflammatory Antiasthmatic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Need for Acute Attack of Asthma
6.2.2 Treatment of Chronic Asthma
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antiasthmatic Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antiasthmatic Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027
9.6.2 Bronchodilators
9.6.3 Anti-allergic Antiasthmatic
9.6.4 Anti-inflammatory Antiasthmatic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Need for Acute Attack of Asthma
9.10.2 Treatment of Chronic Asthma
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027
10.6.2 Bronchodilators
10.6.3 Anti-allergic Antiasthmatic
10.6.4 Anti-inflammatory Antiasthmatic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Need for Acute Attack of Asthma
10.10.2 Treatment of Chronic Asthma
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027
11.6.2 Bronchodilators
11.6.3 Anti-allergic Antiasthmatic
11.6.4 Anti-inflammatory Antiasthmatic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Need for Acute Attack of Asthma
11.10.2 Treatment of Chronic Asthma
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027
12.6.2 Bronchodilators
12.6.3 Anti-allergic Antiasthmatic
12.6.4 Anti-inflammatory Antiasthmatic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Need for Acute Attack of Asthma
12.10.2 Treatment of Chronic Asthma
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Global Antiasthmatic Drug Market Size Growth Rate by Way of Action: 2016 VS 2021 VS 2027
13.6.2 Bronchodilators
13.6.3 Anti-allergic Antiasthmatic
13.6.4 Anti-inflammatory Antiasthmatic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Need for Acute Attack of Asthma
13.10.2 Treatment of Chronic Asthma
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antiasthmatic Drug Market: Competitive Dashboard
14.2 Global Antiasthmatic Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis AG
14.3.2 GlaxoSmithKline
14.3.3 ABC Farmaceutici Spa
14.3.4 AstraZeneca
14.3.5 Teva Pharmaceutical Industries Ltd
14.3.6 Mundipharma Pharmaceuticals Ltd.
14.3.7 MSD
14.3.8 Daiichi Sankyo Company Limited
14.3.9 Chiesi GmbH
14.3.10 Kyorin Pharmaceutical Co.,Ltd.
14.3.11 Kissei Pharmaceutical Co.Ltd.
14.3.12 Ruiyang Pharmaceutical Co., Ltd
14.3.13 Chiesi Pharmaceutical (Shangai) Co., Ltd
14.3.14 Fuhe Group
14.3.15 Lunan Pharmaceutical Group Co., Ltd
14.3.16 Chengdu Huayu Pharmaceutical Co., Ltd
14.3.17 Kaifeng Kangnuo Pharmaceutical Co., Ltd
14.3.18 Akorn Pharmaceutical Co.Ltd.
14.3.19 Boehringer Ingelheim Pharma GmbH&Co.KG
14.3.20 Covis Pharmaceutical Inc
14.3.21 Roche
